William Blair Maintains ‘Hold’ Rating on Incyte Corporation (INCY), Citing Future Revenue Uncertainties
Incyte Corporation (NASDAQ:INCY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio.
Posts Tagged ‘NASDAQ:INCY’
10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio
Ray Dalio began his investing journey at just 12 years old and went on to gain experience at institutions such as the New York Stock Exchange, Dominick & Dominick LLC, and Shearson...
Jim Cramer Highlighted the Top 10 S&P 500 Winners of the Day
“For much of the tremendous run over the past decade, critics love to point out that most of our gains were coming from a small cadre of tech stocks… Over and over again, ...
Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions
Incyte Corporation (NASDAQ:INCY) is one of the 10 biotech stocks screaming a buy.
10 Biotech Stocks Screaming a Buy
The biotech sector has underperformed the overall market.
Incyte (INCY) Targets $1B Growth by 2029 with New Drug Launches
Incyte Corporation (NASDAQ:INCY) is one of the 8 cheap beginner stocks to buy right now.
8 Cheap Beginner Stocks to Buy Right Now
Talk of a slowing economy has once again gained popularity within economic circles.
Morgan Stanley Maintains Hold Rating on Incyte (INCY) Stock
On June 4, Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Incyte Corporation (NASDAQ:INCY) with a price target of $68.00.
15 Small-Cap Healthcare Stocks Hedge Funds Are Buying
The U.S. healthcare sector has performed better in 2025 compared to the broader market.
Incyte Corporation (NASDAQ:INCY) Q1 2025 Earnings Call Transcript
Operator: On today's call, I am joined by Herve Hoppenot, Pablo Cagnoni, and Christiana Stamoulis, who will deliver our prepared remarks.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
10 Best Immunology Stocks To Buy Now
Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.
12 AI Updates Worth Taking a Look At
In a Bloomberg interview, SandboxAQ CEO Jack Hidary started discussing the company's partnership with Saudi Aramco, which focuses on using AI to convert carbon emissions into ...
Incyte Corporation (NASDAQ:INCY) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Incyte Fourth Quarter 2024 and Full Year Financial and Corporate Update Conference Call and Webcast.
Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth
With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
10 Best Immunotherapy Stocks to Buy Now
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects
Many investors continue to be worried about Incyte’s financial prospects when the patent for the company’s blood cancer medication, Jakafi, expires in 2028.
Incyte Corporation (NASDAQ:INCY) Q3 2024 Earnings Call Transcript
Incyte Corporation (NASDAQ:INCY) Q3 2024 Earnings Call Transcript October 29, 2024Incyte Corporation misses on earnings expectations.
Incyte Corporation (NASDAQ:INCY) Q2 2024 Earnings Call Transcript
Incyte Corporation (NASDAQ:INCY) Q2 2024 Earnings Call Transcript July 30, 2024Incyte Corporation misses on earnings expectations.
Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript
Incyte Corporation misses on earnings expectations. Reported EPS is $0.746 EPS, expectations were $0.88.
12 Best S&P 500 Stocks To Buy According to Analysts
In this piece, we will take a look at the 12 best S&P 500 stocks to buy according to analysts.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
5 Biotech Stocks with Huge Potential
In this article, we will take a look at the 5 biotech stocks with huge potential.
Incyte Corporation (NASDAQ:INCY) Q4 2023 Earnings Call Transcript
Incyte Corporation misses on earnings expectations. Reported EPS is $1.06 EPS, expectations were $1.21.
12 Most Promising Gene Editing Stocks According to Hedge Funds
In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds.
13 Most Promising Healthcare Stocks According to Analysts
In this article, we discuss the 13 most promising healthcare stocks according to analysts.
Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
5 Best Debt Free Stocks To Buy
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.
Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks
In this piece, we will take a look at the 12 biggest healthcare stocks in Jim Simons' stock portfolio.
Top 20 Drug Companies in the US by Revenue
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Incyte Corporation (NASDAQ:INCY) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Incyte Third Quarter Earnings Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation.
5 Cheap Biotech Stocks Smart Investors Are Piling Into
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
13 Best Beaten Down Stocks To Buy Now
In this article, we will be taking a look at the 13 best beaten down stocks to buy now.
15 Worst Performing Biotech Stocks in 2023
In this article, we discuss 15 worst performing biotech stocks in 2023.
Incyte Corporation (NASDAQ:INCY) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to the Incyte Second Quarter Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Incyte Corporation (NASDAQ:INCY) Q1 2023 Earnings Call Transcript
Operator: Hello and welcome to the Incyte First Quarter 2023 Earnings Call and Webcast. A question-and-answer session will follow the formal presentation.
Incyte Corporation (NASDAQ:INCY) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Incyte Fourth Quarter and Full Year Financial Results Conference Call and webcast. As a reminder, this conference is being recorded.
12 Cheap Biotech Stocks To Buy
In this article, we will be taking a look at 12 cheap biotech stocks to buy.
Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks
In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks.
5 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
In this article, we will take a look at some important pharma stock picks of Steven Boyd's Armistice Capital.
Analysts Are Downgrading These 10 Stocks
In this article, we will take a look at the 10 stocks that were recently downgraded by analysts.
5 Biotech Stocks to Buy According to Billionaire David E. Shaw
In this piece, we will take a look at five biotechnology stocks to buy according to billionaire David E. Shaw.
Hedge Fund and Insider Trading News: Clifford Asness, Farallon Capital Management, BlueCrest Capital Management, Marshall Wace LLP, Fir Tree Capital Management, Alden Global Capital, Aravt Global LLC, Reservoir Media Inc (RSVR), DoorDash, Inc. (DASH), and More
Hedge fund titan Clifford Asness joined traders in slamming the London Metal Exchange after the platform cancelled trades – a move that may have helped stem losses at a fund...
Did The Smart Money Get Incyte Corporation (INCY) Right?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file ...
Hedge Fund and Insider Trading News: Catherine Wood, Dan Loeb, Ray Dalio, Millennium Management, Chessica LP, Incyte Corporation (INCY), Verastem, Inc. (VSTM), and More
Billionaire investor Ray Dalio has said the Federal Reserve's tightening of monetary policy in 2022 shouldn't derail the economic expansion, but is likely to weigh heavily on "...
Here is What Hedge Funds Think About Incyte Corporation (INCY)
In this article you are going to find out whether hedge funds think Incyte Corporation (NASDAQ:INCY) is a good investment right now.
Hedge Funds Are Nibbling On Incyte Corporation (INCY)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Why These 5 Stocks Are on the Move on Wednesday
In this article we take a look at five stocks on the move on Wednesday.
Hedge Funds Are Selling Incyte Corporation (INCY)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
